NCT03352856 (BALA) is a NA clinical trial of Barley starch in Allergy;Food, sponsored by Lyckeby Starch AB.

Who is sponsoring NCT03352856?

NCT03352856 is sponsored by Lyckeby Starch AB.

What drugs are being tested in NCT03352856?

Interventions in NCT03352856: Barley starch, Maize starch.

What condition does NCT03352856 study?

NCT03352856 studies Allergy;Food, Allergy Wheat.

Is NCT03352856 still recruiting?

NCT03352856 is currently suspended. Last updated 5 March 2019.

Last reviewed 2019-03-05 · How we verify

NCT03352856: BALA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Food Challenge With Barley Starch as Active Comparator

Suspended NA Last updated 5 March 2019

What this trial tests

NA trial testing Barley starch in Allergy;Food in 40 participants. Suspended.

Timeline

13 October 2017

Primary endpoint
31 December 2020

31 March 2021

Quick facts

Lead sponsor	Lyckeby Starch AB
Phase	NA
Status	Suspended
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	basic science
Enrollment	40
Start date	13 October 2017
Primary completion	31 December 2020
Estimated completion	31 March 2021
Sites	1 location across Finland

Drugs / interventions tested

Barley starch
Maize starch

Conditions studied

Allergy;Food — all drugs for Allergy;Food →
Allergy Wheat — all drugs for Allergy Wheat →

Sponsor

Lyckeby Starch AB

Who can join

Adults 1 to 20, any sex, with Allergy;Food or Allergy Wheat. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the present study is to verify in a double-blind placebo controlled food challenge (DBPCFC) test that highly purified barley starch ingredient do not cause allergic reaction in subjects most potential to get allergic reaction due to ingredient. Hypothesis is that none of the cereal (mostly primarily wheat) allergic subject recruited to the study will obtain allergic reaction neither to placebo nor to the test ingredient. Scoring of symptoms during the challenges will be based on PRACTALL.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Allergy;Food

Currently open trials in the same condition.

NCT05407012 — TRANS-FOODS: Preventing Peanut Allergy Through Improved Understanding of the Transcutaneous Sensitisation Route, Novel F · NA · recruiting
NCT06069492 — Randomized Controlled Trial for Wheat Oral Immunotherapy · NA · recruiting
NCT03667651 — The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants · Phase 3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03352856 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lyckeby Starch AB
Last refreshed: 5 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03352856.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing